Vista Outdoor Inc.’s stock fell slightly early Monday, after the maker of sports and outdoor…
Biopharmaceuticals
-
-
STOCK MARKET
Viking Therapeutics takes advantage of soaring stock price to issue fresh shares at a discount
by userby userViking Therapeutics Inc., the clinical-stage biotech that wowed investors this week with promising data from…
-
STOCK MARKET
Viking Therapeutics’ weight-loss drug data makes company takeover target
by userby userViking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to 145%,…
-
STOCK MARKET
Viking Therapeutics’ stock doubles after company reports positive results in trial of weight-loss drug
by userby userViking Therapeutics Inc.’s stock soared 100% early Tuesday, after the company announced positive results from…
-
STOCK MARKET
We’re spending more on leisure and travel. These 11 stocks will soak it up.
by userby userLeisure stocks are likely to outperform this year as emboldened consumers kick back and relax.…
-
STOCK MARKET
AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira
by userby userAbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday,…
-
RAPT Therapeutics Inc. shares RAPT, +1.68% dropped more than 60% premarket on Tuesday after the…
-
STOCK MARKET
Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze
by userby userViking Therapeutics Inc.’s stock soared 17% to a record high on Thursday, after the company…
-
STOCK MARKET
Amgen’s quarterly results top expectations despite Enbrel sales decline
by userby userAmgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as revenues…
-
STOCK MARKET
Novartis to bolster its oncology portfolio with acquisition of MorphoSys
by userby userNovartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys AG…